Replimune (REPL) Asset Utilization Ratio (2018)
Replimune's Asset Utilization Ratio came in at 0.01 for fiscal Q3 2019 (quarter ended Dec 31, 2018), up 34.7% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Asset Utilization Ratio (2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 0.45 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 0.47 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.31 |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.00 |
API Access
Replimune Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();